Effective Inhibition of Rifampicin-resistant Chlamydia Trachomatis by the Novel DNA-dependent RNA Polymerase Inhibitor Corallopyronin A
Overview
Pharmacology
Authors
Affiliations
Fexinidazole and Corallopyronin A target -infected sheath cells present in filarial nematodes.
Chappell L, Peguero R, Conner W, Fowler S, Cooper B, Pfarr K bioRxiv. 2025; .
PMID: 39896488 PMC: 11785234. DOI: 10.1101/2025.01.23.634442.
Harnessing Gram-negative bacteria for novel anti-Gram-negative antibiotics.
Birkelbach J, Seyfert C, Walesch S, Muller R Microb Biotechnol. 2024; 17(11):e70032.
PMID: 39487848 PMC: 11531245. DOI: 10.1111/1751-7915.70032.
Graspeuntner S, Koethke K, Scholz C, Semmler L, Lupatsii M, Kirchhoff L Antibiotics (Basel). 2023; 12(5).
PMID: 37237698 PMC: 10215493. DOI: 10.3390/antibiotics12050795.
Towards the sustainable discovery and development of new antibiotics.
Miethke M, Pieroni M, Weber T, Bronstrup M, Hammann P, Halby L Nat Rev Chem. 2023; 5(10):726-749.
PMID: 37118182 DOI: 10.1038/s41570-021-00313-1.
Pharmacokinetics and Pharmacodynamics (PK/PD) of Corallopyronin A against Methicillin-Resistant .
Rox K, Becker T, Schiefer A, Grosse M, Ehrens A, Jansen R Pharmaceutics. 2023; 15(1).
PMID: 36678760 PMC: 9860980. DOI: 10.3390/pharmaceutics15010131.